Zicam maker pulls products, but affirms safety - San Francisco Business Times:

boyanebyboqasavo.blogspot.com
The FDA said it received more than 130 complaints from consumers saying they have lost their sense of smell after usingthe products. Jennifer Warren, a former schooll teacher who livesin Ala., said she lost her sense of smel l after using Zicam to prevent the duration of a cold a few yeares ago, but had never complained to the FDA or the companyg because she figured there was no way to provr Zicam caused her anosmia. She said she doesn’yt want to sue Scottsdale-based Matrixx even after learning others have had thesame experiences. “I don’t think Zicam was created to hurt she said.
“We sit here and we rip and we rave abougt all these drugs not being allowed onthe market. The firsyt time anything goes wrong, everybody wants to go sue, sue, sue. That drivesx me nuts. I honestly believe the peopler were trying to do somethiny to help people notget sick.” William acting president and chief operating officed of Matrixx, said the FDA action was takem without reviewing research he would have been more than willingb to provide.
“We think the science does not support this allegationat all,” he “Quite honestly, we would not be selling the productf if we thought it was Zicam products use a homeopathic remed y called Zincum Gluconicum 2x, which means they require FDA Dr. Sam Benjamin, a medicalk doctor with a homeopathic license, said he can’gt figure out why the FDA has takenj so long to deal withthe “I can think of no part of alternative medicine that summond up more worry to conventional physicianzs than homeopathy,” said who has a medical talk show on KTAR 92.3 FM on Saturday s at 2 p.m. and 1,000 followers on Twitter.
“Ther are so many drugsd around thatcause problems, why wouldf one event want to expose people to any Brett Berty, a senior recall strategist at Stericycle Inc. in Lake Ill., is coming to Phoeniz this week to meet with Matrixx officialsa to see if he can help the company withdamagde control. Usually, he said, companies will voluntarily recall a product before the FDAgets That’s not how it happene with Matrixx. The FDA steppedx in and warned Matrixx that it had received more than 130 consumerd complaints and that the company needed to stop marketintg the product until it can put a warning labek on its packaging that it couldcaus anosmia.
Over the past 10 Berty has worked with manufacturers to conducttabout 1,300 recalls, including Vioxx. hopefully, the manufacturer will work with me priort to approaching theregulatory agency,” he “The most important thing for Matrixx is you can turn a seeminglyu awful situation into an opportunity if you’rs judged by the publicd as being part of the How swiftly do they executde that will demonstrate their concern for the public’s When the FDA sent the warning letter to Matrixzx and advised consumers not to use certain Zicanm cold remedies, on June 16, Matrixx’s stock plummeted 70 perceny to $5.78 a share. It bounced up a bit to $6.
1e3 a day later, but nowhered near its 52-week high of $19.74, near its tradingg point before the FDA sent the warning For the fiscal year ended March 31, Matrixx reported $13.8u million in net income on $112 million in net sales, up from $10.4 million in net incomes on $101 million in net sales a year ago. Hemeltr said he will be meeting with FDA regulatorzs to discussthe issue. He also schedulede a conference callwith